Arcus Biosciences Inc (RCUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 354,617 | 9,461 | 9,461 | 9,461 | 9,970 |
| Gross Profit | 354,617 | 9,461 | 9,461 | 9,461 | 9,970 |
| Operating Expenses | 73,598 | 87,597 | 85,597 | 82,208 | 61,747 |
| Operating Income | 281,019 | -78,136 | -76,136 | -72,747 | -51,777 |
| Other Income | 519 | 161 | 166 | 154 | -218 |
| Pre-tax Income | 281,538 | -77,975 | -75,970 | -72,593 | -51,995 |
| Net Income Continuous | 279,538 | -77,975 | -75,970 | -72,593 | -51,995 |
| Net Income | $279,538 | $-77,975 | $-75,970 | $-72,593 | $-51,995 |
| EPS Basic Total Ops | 4.04 | -1.11 | -1.09 | -1.08 | -0.71 |
| EPS Basic Continuous Ops | 4.05 | -1.11 | -1.09 | -1.08 | -0.72 |
| EPS Diluted Total Ops | 3.99 | -1.11 | -1.09 | -1.08 | -0.71 |
| EPS Diluted Continuous Ops | 4.00 | -1.11 | -1.09 | -1.08 | -0.72 |
| EBITDA(a) | $284,632 | $-75,781 | $-74,410 | $-71,441 | $-51,367 |